These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2725417)

  • 41. Sensitization and chronic beryllium disease at a primary manufacturing facility, part 2: validation of historical exposures.
    Park JY; Virji MA; Stefaniak AB; Stanton ML; Day GA; Kent MS; Schuler CR; Kreiss K
    Scand J Work Environ Health; 2012 May; 38(3):259-69. PubMed ID: 21847507
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic and exposure risks for chronic beryllium disease.
    Maier LA
    Clin Chest Med; 2002 Dec; 23(4):827-39. PubMed ID: 12516537
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Chronic beryllium disease: a model of interaction between environmental exposure and genetic predisposition. Pathogenesis and clinical features (Part 2)].
    Marchand-Adam S; Guillon F; Brauner M; Valeyre D
    Rev Mal Respir; 2005 Apr; 22(2 Pt 1):271-87. PubMed ID: 16092165
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk.
    Newman LS; Mroz MM; Balkissoon R; Maier LA
    Am J Respir Crit Care Med; 2005 Jan; 171(1):54-60. PubMed ID: 15374840
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of HLA-DRPhebeta47 as the susceptibility marker of hypersensitivity to beryllium in individuals lacking the berylliosis-associated supratypic marker HLA-DPGlubeta69.
    Amicosante M; Berretta F; Rossman M; Butler RH; Rogliani P; van den Berg-Loonen E; Saltini C
    Respir Res; 2005 Aug; 6(1):94. PubMed ID: 16098233
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Considerations for the development of health-based surface dust cleanup criteria for beryllium.
    Shay E; De Gandiaga E; Madl AK
    Crit Rev Toxicol; 2013 Mar; 43(3):220-43. PubMed ID: 23445217
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Occupational Exposure to Beryllium. Final rule.
    Occupational Safety and Health Administration (OSHA), Department of Labor
    Fed Regist; 2017 Jan; 82(5):2470-757. PubMed ID: 28071878
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Beryllium: a modern industrial hazard.
    Kreiss K; Day GA; Schuler CR
    Annu Rev Public Health; 2007; 28():259-77. PubMed ID: 17094767
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Industries in the United States with airborne beryllium exposure and estimates of the number of current workers potentially exposed.
    Henneberger PK; Goe SK; Miller WE; Doney B; Groce DW
    J Occup Environ Hyg; 2004 Oct; 1(10):648-59. PubMed ID: 15631056
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chronic beryllium disease and beryllium sensitization at Rocky Flats: a case-control study.
    Viet SM; Torma-Krajewski J; Rogers J
    AIHAJ; 2000; 61(2):244-54. PubMed ID: 10782196
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sensitization and chronic beryllium disease at a primary manufacturing facility, part 1: historical exposure reconstruction.
    Virji MA; Park JY; Stefaniak AB; Stanton ML; Day GA; Kent MS; Kreiss K; Schuler CR
    Scand J Work Environ Health; 2012 May; 38(3):247-58. PubMed ID: 21850365
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exposure-response analysis for beryllium sensitization and chronic beryllium disease among workers in a beryllium metal machining plant.
    Madl AK; Unice K; Brown JL; Kolanz ME; Kent MS
    J Occup Environ Hyg; 2007 Jun; 4(6):448-66. PubMed ID: 17474035
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chronic beryllium disease and sensitization at a beryllium processing facility.
    Rosenman K; Hertzberg V; Rice C; Reilly MJ; Aronchick J; Parker JE; Regovich J; Rossman M
    Environ Health Perspect; 2005 Oct; 113(10):1366-72. PubMed ID: 16203248
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is beryllium disease a fossil?--not yet.
    Ratney RS
    Int Arch Occup Environ Health; 2001 Apr; 74(3):159-61. PubMed ID: 11355288
    [No Abstract]   [Full Text] [Related]  

  • 55. Beryllium-ferritin: lymphocyte proliferation and macrophage apoptosis in chronic beryllium disease.
    Sawyer RT; Day BJ; Fadok VA; Chiarappa-Zucca M; Maier LA; Fontenot AP; Silveira L; Newman LS
    Am J Respir Cell Mol Biol; 2004 Oct; 31(4):470-7. PubMed ID: 15256386
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Beryllium particulate exposure and disease relations in a beryllium machining plant.
    Kelleher PC; Martyny JW; Mroz MM; Maier LA; Ruttenber AJ; Young DA; Newman LS
    J Occup Environ Med; 2001 Mar; 43(3):238-49. PubMed ID: 11285872
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The value of beryllium determinations in the diagnosis of berylliosis.
    DUTRA FR; CHOLAK J; HUBBARD DM
    Am J Clin Pathol; 1949 Mar; 19(3):229-34. PubMed ID: 18114454
    [No Abstract]   [Full Text] [Related]  

  • 58. Beryllium in exhaled breath condensate as a biomarker of occupational exposure in a primary aluminum production plant.
    Hulo S; Radauceanu A; Chérot-Kornobis N; Howsam M; Vacchina V; De Broucker V; Rousset D; Grzebyk M; Dziurla M; Sobaszek A; Edme JL
    Int J Hyg Environ Health; 2016 Jan; 219(1):40-7. PubMed ID: 26306830
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Re: Sarcoidosis affecting the periodontium: a long-term follow-up. Moretti AJ, Fiocchi MF, Fialtz CM. (J Periodontol 2007;78:2209-2215).
    Guzzi G; Brambilla L; Pigatto PD
    J Periodontol; 2008 Jun; 79(6):978; author reply 978. PubMed ID: 18533772
    [No Abstract]   [Full Text] [Related]  

  • 60. Beryllium and berylliosis.
    SCHUBERT J
    Sci Am; 1958 Aug; 199(2):27-33. PubMed ID: 13580272
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.